| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glycogen phosphorylase activity | 7.45e-09 | 3 | 40 | 3 | GO:0008184 | |
| GeneOntologyMolecularFunction | 1,4-alpha-oligoglucan phosphorylase activity | 7.43e-08 | 5 | 40 | 3 | GO:0004645 | |
| GeneOntologyMolecularFunction | pyridoxal phosphate binding | 8.82e-08 | 56 | 40 | 5 | GO:0030170 | |
| GeneOntologyMolecularFunction | vitamin B6 binding | 9.66e-08 | 57 | 40 | 5 | GO:0070279 | |
| GeneOntologyMolecularFunction | glycine hydroxymethyltransferase activity | 3.91e-06 | 2 | 40 | 2 | GO:0004372 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 5.95e-06 | 18 | 40 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.15e-05 | 70 | 40 | 4 | GO:0003777 | |
| GeneOntologyMolecularFunction | threonine aldolase activity | 1.17e-05 | 3 | 40 | 2 | GO:0004793 | |
| GeneOntologyMolecularFunction | L-allo-threonine aldolase activity | 1.17e-05 | 3 | 40 | 2 | GO:0008732 | |
| GeneOntologyMolecularFunction | vitamin binding | 1.68e-05 | 161 | 40 | 5 | GO:0019842 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 2.36e-05 | 28 | 40 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 5.52e-05 | 37 | 40 | 3 | GO:0045505 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 6.12e-05 | 211 | 40 | 5 | GO:0016758 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 8.99e-05 | 118 | 40 | 4 | GO:0003774 | |
| GeneOntologyMolecularFunction | hydroxymethyl-, formyl- and related transferase activity | 1.09e-04 | 8 | 40 | 2 | GO:0016742 | |
| GeneOntologyMolecularFunction | carbon-carbon lyase activity | 1.92e-04 | 56 | 40 | 3 | GO:0016830 | |
| GeneOntologyMolecularFunction | aldehyde-lyase activity | 2.13e-04 | 11 | 40 | 2 | GO:0016832 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 2.62e-04 | 288 | 40 | 5 | GO:0016757 | |
| GeneOntologyMolecularFunction | myosin phosphatase activity | 6.56e-04 | 85 | 40 | 3 | GO:0017018 | |
| GeneOntologyMolecularFunction | AMP binding | 8.02e-04 | 21 | 40 | 2 | GO:0016208 | |
| GeneOntologyMolecularFunction | enzyme-substrate adaptor activity | 9.07e-04 | 95 | 40 | 3 | GO:0140767 | |
| GeneOntologyMolecularFunction | protein serine/threonine phosphatase activity | 1.35e-03 | 109 | 40 | 3 | GO:0004722 | |
| GeneOntologyMolecularFunction | protein phosphatase 1 binding | 2.23e-03 | 35 | 40 | 2 | GO:0008157 | |
| GeneOntologyMolecularFunction | carbohydrate binding | 3.35e-03 | 310 | 40 | 4 | GO:0030246 | |
| GeneOntologyMolecularFunction | acetylglucosaminyltransferase activity | 4.00e-03 | 47 | 40 | 2 | GO:0008375 | |
| GeneOntologyMolecularFunction | phosphoprotein phosphatase activity | 6.38e-03 | 189 | 40 | 3 | GO:0004721 | |
| GeneOntologyMolecularFunction | phosphoric ester hydrolase activity | 7.26e-03 | 386 | 40 | 4 | GO:0042578 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 7.31e-03 | 614 | 40 | 5 | GO:0140657 | |
| GeneOntologyMolecularFunction | lyase activity | 8.73e-03 | 212 | 40 | 3 | GO:0016829 | |
| GeneOntologyBiologicalProcess | glycogen catabolic process | 6.08e-07 | 35 | 40 | 4 | GO:0005980 | |
| GeneOntologyBiologicalProcess | glucan catabolic process | 6.83e-07 | 36 | 40 | 4 | GO:0009251 | |
| GeneOntologyBiologicalProcess | polysaccharide catabolic process | 8.53e-07 | 38 | 40 | 4 | GO:0000272 | |
| GeneOntologyBiologicalProcess | glycogen metabolic process | 1.32e-06 | 99 | 40 | 5 | GO:0005977 | |
| GeneOntologyBiologicalProcess | glucan metabolic process | 1.46e-06 | 101 | 40 | 5 | GO:0044042 | |
| GeneOntologyBiologicalProcess | energy reserve metabolic process | 2.66e-06 | 114 | 40 | 5 | GO:0006112 | |
| GeneOntologyBiologicalProcess | glycine biosynthetic process from serine | 3.67e-06 | 2 | 40 | 2 | GO:0019264 | |
| GeneOntologyBiologicalProcess | polysaccharide metabolic process | 4.35e-06 | 126 | 40 | 5 | GO:0005976 | |
| GeneOntologyBiologicalProcess | energy derivation by oxidation of organic compounds | 9.13e-05 | 385 | 40 | 6 | GO:0015980 | |
| GeneOntologyBiologicalProcess | central nervous system myelin formation | 1.31e-04 | 9 | 40 | 2 | GO:0032289 | |
| GeneOntologyBiologicalProcess | glycine biosynthetic process | 1.31e-04 | 9 | 40 | 2 | GO:0006545 | |
| GeneOntologyBiologicalProcess | negative regulation of axonogenesis | 2.36e-04 | 62 | 40 | 3 | GO:0050771 | |
| GeneOntologyBiologicalProcess | L-serine metabolic process | 2.82e-04 | 13 | 40 | 2 | GO:0006563 | |
| GeneOntologyBiologicalProcess | tetrahydrofolate interconversion | 4.33e-04 | 16 | 40 | 2 | GO:0035999 | |
| GeneOntologyBiologicalProcess | inner dynein arm assembly | 4.90e-04 | 17 | 40 | 2 | GO:0036159 | |
| GeneOntologyBiologicalProcess | generation of precursor metabolites and energy | 5.06e-04 | 529 | 40 | 6 | GO:0006091 | |
| GeneOntologyBiologicalProcess | carbohydrate catabolic process | 5.53e-04 | 196 | 40 | 4 | GO:0016052 | |
| GeneOntologyBiologicalProcess | glycine metabolic process | 6.14e-04 | 19 | 40 | 2 | GO:0006544 | |
| GeneOntologyBiologicalProcess | tetrahydrofolate metabolic process | 9.04e-04 | 23 | 40 | 2 | GO:0046653 | |
| GeneOntologyCellularComponent | inner dynein arm | 8.32e-07 | 10 | 41 | 3 | GO:0036156 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 1.56e-05 | 25 | 41 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | PTW/PP1 phosphatase complex | 7.83e-05 | 7 | 41 | 2 | GO:0072357 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | 9.84e-05 | 238 | 41 | 5 | GO:0097729 | |
| GeneOntologyCellularComponent | dynein complex | 1.62e-04 | 54 | 41 | 3 | GO:0030286 | |
| GeneOntologyCellularComponent | microtubule associated complex | 2.75e-04 | 161 | 41 | 4 | GO:0005875 | |
| GeneOntologyCellularComponent | motile cilium | 6.23e-04 | 355 | 41 | 5 | GO:0031514 | |
| GeneOntologyCellularComponent | protein phosphatase type 1 complex | 6.28e-04 | 19 | 41 | 2 | GO:0000164 | |
| GeneOntologyCellularComponent | axoneme | 7.10e-04 | 207 | 41 | 4 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 7.23e-04 | 208 | 41 | 4 | GO:0097014 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 3.38e-03 | 317 | 41 | 4 | GO:0032838 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 3.59e-03 | 157 | 41 | 3 | GO:0098839 | |
| GeneOntologyCellularComponent | Cul2-RING ubiquitin ligase complex | 3.84e-03 | 47 | 41 | 2 | GO:0031462 | |
| Domain | Glyco_trans_35 | 8.42e-09 | 3 | 39 | 3 | IPR000811 | |
| Domain | PHOSPHORYLASE | 8.42e-09 | 3 | 39 | 3 | PS00102 | |
| Domain | Phosphorylase | 8.42e-09 | 3 | 39 | 3 | PF00343 | |
| Domain | Glycg_phsphrylas | 8.42e-09 | 3 | 39 | 3 | IPR011833 | |
| Domain | Dynein_heavy_chain_D4_dom | 3.02e-06 | 14 | 39 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 3.02e-06 | 14 | 39 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 3.02e-06 | 14 | 39 | 3 | IPR013602 | |
| Domain | DHC_N2 | 3.02e-06 | 14 | 39 | 3 | PF08393 | |
| Domain | MT | 3.02e-06 | 14 | 39 | 3 | PF12777 | |
| Domain | AAA_8 | 3.02e-06 | 14 | 39 | 3 | PF12780 | |
| Domain | DHC_fam | 3.76e-06 | 15 | 39 | 3 | IPR026983 | |
| Domain | Dynein_heavy_dom | 3.76e-06 | 15 | 39 | 3 | IPR004273 | |
| Domain | Dynein_heavy | 3.76e-06 | 15 | 39 | 3 | PF03028 | |
| Domain | SHMT | 4.25e-06 | 2 | 39 | 2 | PS00096 | |
| Domain | Ser_HO-MeTrfase | 4.25e-06 | 2 | 39 | 2 | IPR001085 | |
| Domain | SHMT | 4.25e-06 | 2 | 39 | 2 | PF00464 | |
| Domain | Ser_HO-MeTrfase_PLP_BS | 4.25e-06 | 2 | 39 | 2 | IPR019798 | |
| Domain | STPPase_N | 1.27e-05 | 3 | 39 | 2 | PF16891 | |
| Domain | STPPase_N | 1.27e-05 | 3 | 39 | 2 | IPR031675 | |
| Domain | Ser/Thr-sp_prot-phosphatase | 3.27e-04 | 13 | 39 | 2 | IPR006186 | |
| Domain | SER_THR_PHOSPHATASE | 3.27e-04 | 13 | 39 | 2 | PS00125 | |
| Domain | PP2Ac | 3.27e-04 | 13 | 39 | 2 | SM00156 | |
| Domain | ATPase_dyneun-rel_AAA | 3.81e-04 | 14 | 39 | 2 | IPR011704 | |
| Domain | AAA_5 | 3.81e-04 | 14 | 39 | 2 | PF07728 | |
| Domain | Calcineurin-like_PHP_ApaH | 1.55e-03 | 28 | 39 | 2 | IPR004843 | |
| Domain | Metallophos | 1.55e-03 | 28 | 39 | 2 | PF00149 | |
| Domain | Metallo-depent_PP-like | 1.78e-03 | 30 | 39 | 2 | IPR029052 | |
| Domain | - | 1.78e-03 | 30 | 39 | 2 | 3.60.21.10 | |
| Domain | - | 2.42e-03 | 35 | 39 | 2 | 3.90.1150.10 | |
| Domain | PyrdxlP-dep_Trfase_major_sub2 | 2.56e-03 | 36 | 39 | 2 | IPR015422 | |
| Domain | - | 3.00e-03 | 39 | 39 | 2 | 3.40.640.10 | |
| Domain | PyrdxlP-dep_Trfase | 3.31e-03 | 41 | 39 | 2 | IPR015424 | |
| Domain | PyrdxlP-dep_Trfase_major_sub1 | 3.31e-03 | 41 | 39 | 2 | IPR015421 | |
| Domain | AAA+_ATPase | 3.35e-03 | 144 | 39 | 3 | IPR003593 | |
| Domain | AAA | 3.35e-03 | 144 | 39 | 3 | SM00382 | |
| Domain | - | 4.89e-03 | 50 | 39 | 2 | 2.60.120.40 | |
| Domain | Tumour_necrosis_fac-like_dom | 6.52e-03 | 58 | 39 | 2 | IPR008983 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION | 8.84e-07 | 9 | 32 | 3 | M47621 | |
| Pathway | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | 3.80e-06 | 14 | 32 | 3 | M19193 | |
| Pathway | KEGG_INSULIN_SIGNALING_PATHWAY | 1.31e-05 | 137 | 32 | 5 | M18155 | |
| Pathway | REACTOME_GLYCOGEN_METABOLISM | 2.36e-05 | 25 | 32 | 3 | M27857 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 2.99e-05 | 27 | 32 | 3 | M47755 | |
| Pathway | WP_GLYCOGEN_METABOLISM | 6.06e-05 | 34 | 32 | 3 | MM15985 | |
| Pathway | WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION | 9.92e-05 | 40 | 32 | 3 | M39595 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 1.23e-04 | 43 | 32 | 3 | M47669 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_MRAS_SHOC2_PP1_HOLOPHOSPHATASE | 1.39e-04 | 8 | 32 | 2 | M47933 | |
| Pathway | WP_SERINE_METABOLISM | 1.39e-04 | 8 | 32 | 2 | M42556 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 1.41e-04 | 45 | 32 | 3 | M47670 | |
| Pathway | BIOCARTA_FEEDER_PATHWAY | 1.78e-04 | 9 | 32 | 2 | M3061 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 2.18e-04 | 52 | 32 | 3 | M14171 | |
| Pathway | REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN_1_SIGNALING | 2.22e-04 | 10 | 32 | 2 | M27330 | |
| Pathway | WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING | 2.70e-04 | 140 | 32 | 4 | M42572 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CENPE_INTERACTION_WITH_NDC80_COMPLEX | 3.25e-04 | 12 | 32 | 2 | M47887 | |
| Pathway | KEGG_MEDICUS_REFERENCE_DEPHOSPHORYLATION_OF_KINETOCHORE | 3.25e-04 | 12 | 32 | 2 | M47891 | |
| Pathway | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | 4.47e-04 | 14 | 32 | 2 | MM15391 | |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_RSV_GENOME_REPLICATION_TRANSCRIPTION_AND_TRANSLATION | 5.87e-04 | 16 | 32 | 2 | M48235 | |
| Pathway | KEGG_ONE_CARBON_POOL_BY_FOLATE | 6.65e-04 | 17 | 32 | 2 | M12039 | |
| Pathway | REACTOME_METABOLISM_OF_FOLATE_AND_PTERINES | 6.65e-04 | 17 | 32 | 2 | M27085 | |
| Pathway | REACTOME_GLYCOGEN_METABOLISM | 7.47e-04 | 18 | 32 | 2 | MM15577 | |
| Pathway | WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT | 8.33e-04 | 19 | 32 | 2 | M39777 | |
| Pathway | REACTOME_METABOLISM_OF_FOLATE_AND_PTERINES | 1.02e-03 | 21 | 32 | 2 | MM14763 | |
| Pathway | REACTOME_TRIGLYCERIDE_CATABOLISM | 1.34e-03 | 24 | 32 | 2 | M10064 | |
| Pathway | REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING | 1.57e-03 | 26 | 32 | 2 | M628 | |
| Pathway | WP_ONECARBON_METABOLISM | 1.95e-03 | 29 | 32 | 2 | M39471 | |
| Pathway | KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM | 2.23e-03 | 31 | 32 | 2 | M766 | |
| Pathway | PID_NETRIN_PATHWAY | 2.37e-03 | 32 | 32 | 2 | M108 | |
| Pathway | WP_13Q1212_COPY_NUMBER_VARIATION | 2.68e-03 | 34 | 32 | 2 | M48103 | |
| Pathway | WP_ONECARBON_METABOLISM | 2.68e-03 | 34 | 32 | 2 | MM15859 | |
| Pathway | WP_GLUTATHIONE_AND_ONECARBON_METABOLISM | 2.83e-03 | 35 | 32 | 2 | MM15815 | |
| Pubmed | Molecular mechanisms underlying the interaction of protein phosphatase-1c with ASPP proteins. | 3.03e-08 | 6 | 41 | 3 | 23088536 | |
| Pubmed | 5.49e-07 | 14 | 41 | 3 | 9373155 | ||
| Pubmed | 6.85e-07 | 15 | 41 | 3 | 2575583 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 11516159 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 29073064 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 9573390 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 30500180 | ||
| Pubmed | Effect of vitamin B6 availability on serine hydroxymethyltransferase in MCF-7 cells. | 1.36e-06 | 2 | 41 | 2 | 17482557 | |
| Pubmed | Is mutated serine hydroxymethyltransferase (SHMT) involved in the etiology of neural tube defects? | 1.36e-06 | 2 | 41 | 2 | 11386852 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 27530298 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 25130497 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 8505317 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 25619277 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 9882500 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 22220685 | ||
| Pubmed | PP-1α and PP-1γ display antagonism and differential roles in tumorigenicity of lung cancer cells. | 1.36e-06 | 2 | 41 | 2 | 23176181 | |
| Pubmed | 3.03e-06 | 24 | 41 | 3 | 27754788 | ||
| Pubmed | Analysis of a lung defect in autophagy-deficient mouse strains. | 3.88e-06 | 26 | 41 | 3 | 24275123 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 27340655 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 12138106 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 7857673 | ||
| Pubmed | Dynamic targeting of protein phosphatase 1 within the nuclei of living mammalian cells. | 4.06e-06 | 3 | 41 | 2 | 11739654 | |
| Pubmed | Mutually exclusive binding of PP1 and RNA to AKAP149 affects the mitochondrial network. | 4.06e-06 | 3 | 41 | 2 | 19074462 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 11588169 | ||
| Pubmed | Proteomic identification of mitochondrial targets of arginase in human breast cancer. | 4.06e-06 | 3 | 41 | 2 | 24223914 | |
| Pubmed | Acetylation negatively regulates glycogen phosphorylase by recruiting protein phosphatase 1. | 4.06e-06 | 3 | 41 | 2 | 22225877 | |
| Pubmed | 1E7-03, a low MW compound targeting host protein phosphatase-1, inhibits HIV-1 transcription. | 4.06e-06 | 3 | 41 | 2 | 25073485 | |
| Pubmed | Protein phosphatase 1 (PP1) is a post-translational regulator of the mammalian circadian clock. | 4.06e-06 | 3 | 41 | 2 | 21712997 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 19275933 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 17965019 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 9882488 | ||
| Pubmed | Affinity properties of phosvitin: interaction of phosvitin with serine hydroxymethyl transferase. | 4.06e-06 | 3 | 41 | 2 | 10549165 | |
| Pubmed | Characterising the dynamics of placental glycogen stores in the mouse. | 5.44e-06 | 29 | 41 | 3 | 32798765 | |
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 23499489 | ||
| Pubmed | Nuclear targeting of protein phosphatase-1 by HIV-1 Tat protein. | 8.12e-06 | 4 | 41 | 2 | 16131488 | |
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 10194355 | ||
| Pubmed | Myelin-derived ephrinB3 restricts axonal regeneration and recovery after adult CNS injury. | 8.12e-06 | 4 | 41 | 2 | 22411787 | |
| Pubmed | Protein phosphatase 1 inhibits p53 signaling by dephosphorylating and stabilizing Mdmx. | 8.12e-06 | 4 | 41 | 2 | 23277204 | |
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 10880350 | ||
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 12016225 | ||
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 12221103 | ||
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 15226296 | ||
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 22768081 | ||
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 12226088 | ||
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 17202132 | ||
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 10807923 | ||
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 12036952 | ||
| Pubmed | N-CoR controls differentiation of neural stem cells into astrocytes. | 8.12e-06 | 4 | 41 | 2 | 12410313 | |
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 26334248 | ||
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 24902662 | ||
| Pubmed | Nuclear protein phosphatase-1 regulates HIV-1 transcription. | 8.12e-06 | 4 | 41 | 2 | 12788939 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | 1.26e-05 | 1257 | 41 | 9 | 37317656 | |
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 20424263 | ||
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 23197154 | ||
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 12624094 | ||
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 19581931 | ||
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 12016208 | ||
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 22801782 | ||
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 11551964 | ||
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 28615442 | ||
| Pubmed | Association of the type 1 protein phosphatase PP1 with the A-kinase anchoring protein AKAP220. | 1.35e-05 | 5 | 41 | 2 | 10209101 | |
| Pubmed | The interaction of PP1 with BRCA1 and analysis of their expression in breast tumors. | 1.35e-05 | 5 | 41 | 2 | 17511879 | |
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 25487150 | ||
| Pubmed | The nuclear envelope protein, LAP1B, is a novel protein phosphatase 1 substrate. | 1.35e-05 | 5 | 41 | 2 | 24116158 | |
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 39056782 | ||
| Pubmed | 2.03e-05 | 6 | 41 | 2 | 30224412 | ||
| Pubmed | SHMT1 and SHMT2 are functionally redundant in nuclear de novo thymidylate biosynthesis. | 2.03e-05 | 6 | 41 | 2 | 19513116 | |
| Pubmed | 2.03e-05 | 6 | 41 | 2 | 25785436 | ||
| Pubmed | 2.03e-05 | 6 | 41 | 2 | 21998301 | ||
| Pubmed | Protein phosphatase 1 regulates the phosphorylation state of the polarity scaffold Par-3. | 2.03e-05 | 6 | 41 | 2 | 18641122 | |
| Pubmed | SIPP1, a novel pre-mRNA splicing factor and interactor of protein phosphatase-1. | 2.03e-05 | 6 | 41 | 2 | 14640981 | |
| Pubmed | UCHL1 regulates ubiquitination and recycling of the neural cell adhesion molecule NCAM. | 2.03e-05 | 6 | 41 | 2 | 23061666 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 2.26e-05 | 1353 | 41 | 9 | 29467282 | |
| Pubmed | Inhibitor-2 prevents protein phosphatase 1-induced cardiac hypertrophy and mortality. | 2.84e-05 | 7 | 41 | 2 | 18689497 | |
| Pubmed | SARP, a new alternatively spliced protein phosphatase 1 and DNA interacting protein. | 2.84e-05 | 7 | 41 | 2 | 17123353 | |
| Pubmed | 2.84e-05 | 7 | 41 | 2 | 33537097 | ||
| Pubmed | 2.84e-05 | 7 | 41 | 2 | 12147701 | ||
| Pubmed | Association of a protein phosphatase 1 activity with the human factor C1 (HCF) complex. | 2.84e-05 | 7 | 41 | 2 | 10637318 | |
| Pubmed | 2.84e-05 | 7 | 41 | 2 | 26138980 | ||
| Pubmed | 3.78e-05 | 8 | 41 | 2 | 12036313 | ||
| Pubmed | 3.78e-05 | 8 | 41 | 2 | 16262633 | ||
| Pubmed | 3.78e-05 | 8 | 41 | 2 | 21930935 | ||
| Pubmed | The LMO2 oncogene regulates DNA replication in hematopoietic cells. | 4.49e-05 | 58 | 41 | 3 | 26764384 | |
| Pubmed | RRP1B targets PP1 to mammalian cell nucleoli and is associated with Pre-60S ribosomal subunits. | 4.86e-05 | 9 | 41 | 2 | 20926688 | |
| Pubmed | 4.86e-05 | 9 | 41 | 2 | 10704386 | ||
| Pubmed | 4.86e-05 | 9 | 41 | 2 | 10683176 | ||
| Pubmed | 4.86e-05 | 9 | 41 | 2 | 21566083 | ||
| Pubmed | 4.86e-05 | 9 | 41 | 2 | 15599401 | ||
| Pubmed | Rearrangement of the Protein Phosphatase 1 Interactome During Heart Failure Progression. | 5.30e-05 | 174 | 41 | 4 | 29669786 | |
| Pubmed | ILF3 is a substrate of SPOP for regulating serine biosynthesis in colorectal cancer. | 7.41e-05 | 11 | 41 | 2 | 31772275 | |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | 8.36e-05 | 621 | 41 | 6 | 22794259 | |
| Pubmed | 8.58e-05 | 197 | 41 | 4 | 36604605 | ||
| Pubmed | 8.88e-05 | 12 | 41 | 2 | 10830164 | ||
| Pubmed | Multiple influences on the migration of precerebellar neurons in the caudal medulla. | 8.88e-05 | 12 | 41 | 2 | 11807023 | |
| Pubmed | Docking motif-guided mapping of the interactome of protein phosphatase-1. | 1.17e-04 | 80 | 41 | 3 | 19389623 | |
| Pubmed | 1.22e-04 | 14 | 41 | 2 | 16048649 | ||
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | 1.31e-04 | 420 | 41 | 5 | 28065597 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | 1.32e-04 | 1321 | 41 | 8 | 27173435 | |
| Pubmed | BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis. | 1.41e-04 | 15 | 41 | 2 | 12931191 | |
| Pubmed | 1.61e-04 | 16 | 41 | 2 | 17683050 | ||
| Interaction | PPP1R3B interactions | 3.65e-08 | 19 | 37 | 4 | int:PPP1R3B | |
| Interaction | PYGB interactions | 8.20e-06 | 152 | 37 | 5 | int:PYGB | |
| Interaction | PPP1R3D interactions | 8.56e-06 | 22 | 37 | 3 | int:PPP1R3D | |
| Interaction | PPP1R2C interactions | 1.96e-05 | 4 | 37 | 2 | int:PPP1R2C | |
| Interaction | PYGM interactions | 3.07e-05 | 98 | 37 | 4 | int:PYGM | |
| Interaction | CSRNP2 interactions | 3.27e-05 | 5 | 37 | 2 | int:CSRNP2 | |
| Interaction | SFRP2 interactions | 3.58e-05 | 35 | 37 | 3 | int:SFRP2 | |
| Interaction | PPP1R8 interactions | 3.59e-05 | 102 | 37 | 4 | int:PPP1R8 | |
| Interaction | SFRP5 interactions | 4.90e-05 | 6 | 37 | 2 | int:SFRP5 | |
| Interaction | RASSF9 interactions | 4.97e-05 | 39 | 37 | 3 | int:RASSF9 | |
| Interaction | GYS1 interactions | 7.95e-05 | 125 | 37 | 4 | int:GYS1 | |
| Interaction | PYGL interactions | 7.95e-05 | 125 | 37 | 4 | int:PYGL | |
| Interaction | KIF18A interactions | 1.18e-04 | 52 | 37 | 3 | int:KIF18A | |
| Interaction | PRRC1 interactions | 1.40e-04 | 55 | 37 | 3 | int:PRRC1 | |
| Interaction | PPP1R1B interactions | 2.14e-04 | 12 | 37 | 2 | int:PPP1R1B | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7p22 | 2.39e-04 | 134 | 41 | 3 | chr7p22 | |
| Cytoband | 7p22.1 | 8.20e-04 | 47 | 41 | 2 | 7p22.1 | |
| GeneFamily | Glycogen phosphorylases | 3.71e-09 | 3 | 29 | 3 | 437 | |
| GeneFamily | Dyneins, axonemal | 2.49e-06 | 17 | 29 | 3 | 536 | |
| GeneFamily | Protein phosphatase catalytic subunits|EF-hand domain containing | 1.92e-04 | 13 | 29 | 2 | 693 | |
| GeneFamily | Beta 3-glycosyltransferases | 6.71e-04 | 24 | 29 | 2 | 426 | |
| GeneFamily | Proteases, serine | 4.57e-03 | 63 | 29 | 2 | 738 | |
| Coexpression | MOOTHA_GLYCOGEN_METABOLISM | 2.73e-08 | 21 | 40 | 4 | M10376 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-T_&_ILC-ILCP|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.47e-07 | 174 | 41 | 5 | 5e6050d20a5b27640f6a200441125b8ceba123c8 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.21e-05 | 154 | 41 | 4 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.21e-05 | 154 | 41 | 4 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.75e-05 | 169 | 41 | 4 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-Deuterosomal|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.87e-05 | 172 | 41 | 4 | 08ad76412c9cc3504141797b44b88478ced87476 | |
| ToppCell | droplet-Marrow-nan-18m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-05 | 177 | 41 | 4 | 5d70fe2b0592362d664b3b4c84eb450ec2335957 | |
| ToppCell | droplet-Marrow-nan-18m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-05 | 177 | 41 | 4 | 48bcf603ec9593eedd81f3831cf9fde89fad368f | |
| ToppCell | (05)_Ciliated-(4)_1wkpi|(05)_Ciliated / shred by cell type and Timepoint | 2.24e-05 | 180 | 41 | 4 | 85fc9b164147b28545e2397d32302eea03ef6346 | |
| ToppCell | Healthy-MAIT|Healthy / disease group, cell group and cell class | 2.54e-05 | 186 | 41 | 4 | 028061f06d86e75cb06db56b199594b80f23fa58 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-05 | 188 | 41 | 4 | 14e120b20e76baa07b6510a94f0c2dcdfdd52357 | |
| ToppCell | Healthy-MAIT|World / disease group, cell group and cell class | 2.71e-05 | 189 | 41 | 4 | 2404254b7a31b4a931841232e07462a3ca855ad4 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-05 | 189 | 41 | 4 | 443359d90fafae0c1de6bdcce9e8c95df6ea4de8 | |
| ToppCell | facs-Large_Intestine-Proximal-24m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-05 | 190 | 41 | 4 | 933c778bb8ec89621906fe7d484c1d2c6cd28d80 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-05 | 190 | 41 | 4 | c0ee404d705b0b4f0c6ded4d070ad85eac4b16db | |
| ToppCell | Severe-MAIT|World / Disease group and Cell class | 2.76e-05 | 190 | 41 | 4 | 7a92e0d6a021be23125495927b8571e25c83204a | |
| ToppCell | Severe-MAIT|Severe / Disease group and Cell class | 2.76e-05 | 190 | 41 | 4 | 1c063dc1b62d9f9912aaf8d0297555a6545f5550 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.06e-05 | 195 | 41 | 4 | e06ff785c5542c86c335d956799e03f7ae8345a4 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type | 3.06e-05 | 195 | 41 | 4 | 60067b5359174f0d1a8b5748bfc0690762e9e740 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial|Control_saline / Treatment groups by lineage, cell group, cell type | 3.24e-05 | 198 | 41 | 4 | e7aa42e5fbd42c68f50cda4a8f3aa464c862c007 | |
| ToppCell | Control_saline-Epithelial_airway|Control_saline / Treatment groups by lineage, cell group, cell type | 3.24e-05 | 198 | 41 | 4 | e6863238e022ecfb6a8e3f4b7661b376e92c5d8f | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Ciliated|LPS_only / Treatment groups by lineage, cell group, cell type | 3.24e-05 | 198 | 41 | 4 | 6d90b541fde357fbb40f8f7d4e8628a48b679718 | |
| ToppCell | control-MAIT|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.24e-05 | 198 | 41 | 4 | 13955a4026c97e11d94973ac87bf018f64a2616c | |
| ToppCell | Control_saline-Hematopoietic_Myeloid-Granulocytic_cells-Neutrophils|Control_saline / Treatment groups by lineage, cell group, cell type | 3.31e-05 | 199 | 41 | 4 | e1240bfcdce76ec018599c50350748f9c7b8fb0e | |
| ToppCell | LPS_anti-TNF-Epithelial_airway|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.31e-05 | 199 | 41 | 4 | 6aca164bbbb961f34b1e6f1857f91ade5c059405 | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.31e-05 | 199 | 41 | 4 | 60919c2af31d39a2d36d7bc432e43dab2a4e05fb | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.37e-05 | 200 | 41 | 4 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | control-MAIT|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.37e-05 | 200 | 41 | 4 | aeea4bda2e38cc6db571ed2b47ce022d637619bd | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.37e-05 | 200 | 41 | 4 | 31d75c26055177d656df1fbb10b764cebd61e122 | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.37e-05 | 200 | 41 | 4 | 4992dbf0514d674017315dbd20d91dfec0c608e9 | |
| ToppCell | (09)_Interm._secr.>cil.|World / shred by cell type by condition | 3.37e-05 | 200 | 41 | 4 | 3305e14dba12e94da42f0414fdc7a2c8caf0a183 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.37e-05 | 200 | 41 | 4 | e1dce91c6c531bb212002a14705e496d77ad3490 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P2-Tnr|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.35e-05 | 74 | 41 | 3 | 1712898d8dd95f752f5da86307e0eedb7b82a709 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P2-Tnr-Polydendrocyte.Tnr.Bmp4_(Bmp4)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.35e-05 | 74 | 41 | 3 | 0ec7e9c21459e02e8a2fefcc3a2230921ddbb4e8 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P2-Tnr-Polydendrocyte.Tnr.Bmp4_(Bmp4)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.35e-05 | 74 | 41 | 3 | 216dce5613d897ebd620c72b6b1d370c2c766666 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P2|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.35e-05 | 74 | 41 | 3 | a994111e4aa0f19e1a1360b8636a16e10cbaf5d3 | |
| ToppCell | Frontal_cortex-Macroglia-POLYDENDROCYTE-P2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.07e-04 | 100 | 41 | 3 | 3a7e5469de88745ac455c35deeb859d68dce73fa | |
| ToppCell | Frontal_cortex-Macroglia-POLYDENDROCYTE-P2-Tnr|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.07e-04 | 100 | 41 | 3 | 187e31d4186b82a37569b98d83e4813017cc2ddd | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c10-IFNG|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.12e-04 | 126 | 41 | 3 | d19382597ce5c6546731ac1fd33c7dcb7916b2ea | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac1_Htr1d|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.82e-04 | 139 | 41 | 3 | fe1657ef9aeda7c530dc7febcd3dcd0e1d5f8a48 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.88e-04 | 140 | 41 | 3 | a3be1fb7d2eb44bc123456d03250502938d46d9d | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.88e-04 | 140 | 41 | 3 | e442c46979d725ec82f525a001c46d971fcade4d | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.88e-04 | 140 | 41 | 3 | 9f105687f5749399fd76043fd85da58be30f2caf | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-Treg|ICU-SEP / Disease, Lineage and Cell Type | 3.19e-04 | 145 | 41 | 3 | ee99b58462f955b96d036aa67e343db047d66f64 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Macroglial-oligodendrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.53e-04 | 150 | 41 | 3 | afd651c654e715414eff64cf3a37378d057a56a2 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.81e-04 | 154 | 41 | 3 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | Ciliated_cells-A-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 3.81e-04 | 154 | 41 | 3 | 3b938e23324f7edb56797b4a76fb96ff588142cf | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.81e-04 | 154 | 41 | 3 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.88e-04 | 155 | 41 | 3 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.88e-04 | 155 | 41 | 3 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | Influenza_Severe-CD4+_Tcm|World / Disease group and Cell class | 4.03e-04 | 157 | 41 | 3 | 842ac087d3d51dba3a6b6937733b73a81aa15e1b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.34e-04 | 161 | 41 | 3 | 580153e131247e6ec12a1a920f050a0a763e7e87 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.34e-04 | 161 | 41 | 3 | 6d9907e2949a742c0933128fde57832a9ca5f77c | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-Treg|Multiple_Sclerosis / Disease, Lineage and Cell Type | 4.42e-04 | 162 | 41 | 3 | 975d52e3cc101e7592425128e1099d30847a8a42 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-ILC3|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.50e-04 | 163 | 41 | 3 | 00e791358a7eb6c3e95f87afe22153845012e4a1 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.58e-04 | 164 | 41 | 3 | 8f3255d7f67890389a768453492243ea982eb38a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.58e-04 | 164 | 41 | 3 | 4ef776d1bab4103d42d3a4f22cdfb49e8d2bc5a0 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_PP_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-04 | 164 | 41 | 3 | 74a35ba77e93d864161beb6b133d654473981bb7 | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-MAIT|ICU-SEP / Disease, Lineage and Cell Type | 4.58e-04 | 164 | 41 | 3 | db863a44fc0dad5518c47fdbf64ea21d6f36f089 | |
| ToppCell | Mild-Myeloid-Mast-|Mild / Condition, Lineage, Cell class and cell subclass | 4.66e-04 | 165 | 41 | 3 | 93d3909a0f5f43d473d5005c842d7d73e25eceed | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.66e-04 | 165 | 41 | 3 | 9ccce713d4122054bf4bef4a7126d90cf9141b84 | |
| ToppCell | Mild-Myeloid-Mast|Mild / Condition, Lineage, Cell class and cell subclass | 4.66e-04 | 165 | 41 | 3 | 5fa9552c37890c5cc7e672a47038aebba2413cb4 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.66e-04 | 165 | 41 | 3 | dbe231d00843cae917efd1abea6079ace3b45cdf | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-CD8+_T-MAIT-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.74e-04 | 166 | 41 | 3 | bb93db4613c067c56614ab1ca39e73ee46484387 | |
| ToppCell | mild-Lymphocytic-CD4_T_cells_3|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.74e-04 | 166 | 41 | 3 | f8f8423423d72f0ea0266b59126abb27beb23094 | |
| ToppCell | Basal-basal-4|World / Class top | 4.74e-04 | 166 | 41 | 3 | 2721772eb2a9f45c5e9aaf4d73d198fea11a3586 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-CD8+_T-MAIT|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.74e-04 | 166 | 41 | 3 | c1f17a028bb27b8f202bcfffa7de7373b1cdd990 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.83e-04 | 167 | 41 | 3 | 83969c36ac44b96afc9aa09400a99fa2b487f7ff | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.83e-04 | 167 | 41 | 3 | 166b7b4ca0663cde6d88219ee0bcc1988d03dab8 | |
| ToppCell | COVID-19_Moderate-Treg|COVID-19_Moderate / disease group, cell group and cell class | 4.83e-04 | 167 | 41 | 3 | 4ddb21421cbe72c06b61dd3a5eb1337e59de42e5 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.00e-04 | 169 | 41 | 3 | 8bca402e144819cb9a8d431d6bf9429be2fff6d6 | |
| ToppCell | Control-Lymphocyte-T_NK-MAIT|Control / Disease, Lineage and Cell Type | 5.00e-04 | 169 | 41 | 3 | 8c2aac193a9c500f01a99a2ee530839c851b6222 | |
| ToppCell | COVID-19_Moderate-Treg|World / disease group, cell group and cell class | 5.00e-04 | 169 | 41 | 3 | 27ad11239559b025bef582f89b2a83501d9d3993 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_B0|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.00e-04 | 169 | 41 | 3 | 89b5452e0d8d058648a1d2659f1611fd6aebc6b6 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-ILC3|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.00e-04 | 169 | 41 | 3 | d4a0bd792bddfa34332d7dc432ce253f50d98c6f | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-04 | 169 | 41 | 3 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | facs-Heart-LV-3m-Lymphocytic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.08e-04 | 170 | 41 | 3 | 2491f3849e34b0ccd06015fa59d15e3d7963c76d | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.08e-04 | 170 | 41 | 3 | aff226a84e397ab58204325aa9d8b396a881986e | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.08e-04 | 170 | 41 | 3 | 6af16e6f276aec6389ece99505ba13c7edc4c4fa | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-T_cells-ILC3|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.17e-04 | 171 | 41 | 3 | 6ab7f103cbdbd49ef687cbb8a42ddc5517af0f7f | |
| ToppCell | droplet-Heart-4Chambers-21m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.17e-04 | 171 | 41 | 3 | e852d0e8589eecf4a2e5fea039b52a67c5d58dbd | |
| ToppCell | metastatic_Brain-Myeloid_cells-CD207+CD1a+_LCs|Myeloid_cells / Location, Cell class and cell subclass | 5.26e-04 | 172 | 41 | 3 | 38d17e769fe8eac8b57b820490d4ddd969243ee7 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-proerythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-04 | 172 | 41 | 3 | cfcfa7eeff1805bedf10a3c07826459914c3e872 | |
| ToppCell | Control-MAIT|Control / Disease group and Cell class | 5.26e-04 | 172 | 41 | 3 | 552bc62e8e8bb0ac1cd0452f4410a3af087787eb | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-MAIT|Multiple_Sclerosis / Disease, Lineage and Cell Type | 5.26e-04 | 172 | 41 | 3 | 18bda0038cb37da6784e7bf7291272c108cfd9c5 | |
| ToppCell | TCGA-Head_and_Esophagus-Solid_Tissue_Normal-Head_and_Neck-Head_and_Neck_normal_tissue-5|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 5.26e-04 | 172 | 41 | 3 | 6b8a8d3b97c10b9d092307eed3cacbd2745df185 | |
| ToppCell | FLU-Healthy-5|Healthy / Virus stimulation, Condition and Cluster | 5.35e-04 | 173 | 41 | 3 | 8c218ec1ba927e9312f3df5f312395e907ab64ab | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-24m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.35e-04 | 173 | 41 | 3 | ef862e1d626bbc33191b433f483addff7f75ba16 | |
| ToppCell | FLU-Healthy-5|FLU / Virus stimulation, Condition and Cluster | 5.35e-04 | 173 | 41 | 3 | bd4f06d971f9d138749094047c9337dfbaf5da31 | |
| ToppCell | droplet-Marrow-nan-18m-Hematologic-proerythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.35e-04 | 173 | 41 | 3 | 03cee3d24bc433e91a867ce951589de64a0538af | |
| ToppCell | 10x5'-blood-Lymphocytic_Invariant-Inducer-like|blood / Manually curated celltypes from each tissue | 5.44e-04 | 174 | 41 | 3 | 51be6f29308c01593978cbee92114151a5916c9c | |
| ToppCell | PND07-28-samps-Epithelial-Epithelial-non_alveolar-Ciliated_cell_of_lung_parenchyma|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 5.44e-04 | 174 | 41 | 3 | f41d05a3703d7092bd3c4a97c15ae13069aaa4ad | |
| ToppCell | droplet-Marrow-nan-18m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.44e-04 | 174 | 41 | 3 | 4b749ac9f05776c0c56b74daca833bd0b5704299 | |
| ToppCell | Int-URO-Lymphocyte-T_NK-MAIT|Int-URO / Disease, Lineage and Cell Type | 5.44e-04 | 174 | 41 | 3 | 5227ed29f5f0d3e0aaa7f3cfd362f96d3e2660f7 | |
| ToppCell | PND07-28-samps-Epithelial-Epithelial-non_alveolar|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 5.53e-04 | 175 | 41 | 3 | c01a15b2084da4a18f8ff3623f44eb9dfe499f10 | |
| ToppCell | 10x5'-blood-Lymphocytic_Invariant-Inducer-like-MAIT|blood / Manually curated celltypes from each tissue | 5.53e-04 | 175 | 41 | 3 | b4e4b66e89f79999768a6192c8404cb2465f920b | |
| ToppCell | droplet-Marrow-nan-21m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.62e-04 | 176 | 41 | 3 | a5ec032fe39172be11ffdda5af515c8d38731d9a | |
| ToppCell | Ciliated_cells-A-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 5.62e-04 | 176 | 41 | 3 | 1c364155f46b9a7c995bdc2cc2333c437cd90f5b | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.62e-04 | 176 | 41 | 3 | 238244294d08975df6bfa26b2b437db3654408ae | |
| ToppCell | droplet-Marrow-nan-21m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.62e-04 | 176 | 41 | 3 | b1b921f96b6a3cbfbd156d7b74f06c82c4e199d0 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_T-T_NK-NK_T_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.62e-04 | 176 | 41 | 3 | f0c01fc4f9c17c4d724642d9931731eef2b10258 | |
| Drug | AC1L8YNX | 4.25e-10 | 23 | 40 | 5 | CID000410238 | |
| Drug | deoxypyridoxine-P | 6.75e-10 | 57 | 40 | 6 | CID000095687 | |
| Drug | pyridoxal | 3.49e-09 | 135 | 40 | 7 | CID000001050 | |
| Drug | 3,5-dimethylphenyl isocyanate | 5.02e-09 | 3 | 40 | 3 | CID000521488 | |
| Drug | 5-ethyl-4-hydroxy-2-methyl-3(2H)-furanone | 5.02e-09 | 3 | 40 | 3 | CID000093111 | |
| Drug | adenosine-5'-chloromethylphosphonate | 5.02e-09 | 3 | 40 | 3 | CID000191554 | |
| Drug | hydan | 5.02e-09 | 3 | 40 | 3 | CID000008360 | |
| Drug | EHMF | 5.02e-09 | 3 | 40 | 3 | CID000033931 | |
| Drug | 5'-deoxy-5'-fluoro-5'-(methylthio)adenosine | 5.02e-09 | 3 | 40 | 3 | CID000147839 | |
| Drug | pyridoxal 5'-methylenephosphonate | 5.02e-09 | 3 | 40 | 3 | CID003082249 | |
| Drug | Plp 5'-mpa | 5.02e-09 | 3 | 40 | 3 | CID003082151 | |
| Drug | glucose-1,2-cyclic phosphate | 5.02e-09 | 3 | 40 | 3 | CID000191723 | |
| Drug | 3'-FFdUrd | 5.02e-09 | 3 | 40 | 3 | CID000072260 | |
| Drug | 2',3',4',5,5'-pentachloro-2-biphenylol | 5.02e-09 | 3 | 40 | 3 | CID000119518 | |
| Drug | AC1L8XK3 | 5.02e-09 | 3 | 40 | 3 | CID000409735 | |
| Drug | N-acetyl-N'-beta-D-glucopyranosyl urea | 5.02e-09 | 3 | 40 | 3 | CID000446801 | |
| Drug | NSC758405 | 5.02e-09 | 3 | 40 | 3 | CID000003201 | |
| Drug | 3,5-dinitrophenyl phosphate | 5.02e-09 | 3 | 40 | 3 | CID000151920 | |
| Drug | riboflavin tetraacetate | 5.02e-09 | 3 | 40 | 3 | CID000094186 | |
| Drug | pyridoxal phosphoglucose | 5.02e-09 | 3 | 40 | 3 | CID000196007 | |
| Drug | 2,5-dimethyl-3-furanone | 5.02e-09 | 3 | 40 | 3 | CID000085730 | |
| Drug | 3,5-dinitrophenol | 5.02e-09 | 3 | 40 | 3 | CID000011459 | |
| Drug | galocitabine | 2.01e-08 | 4 | 40 | 3 | CID000065950 | |
| Drug | 2,5-anhydro-D-mannitol 1-phosphate | 2.01e-08 | 4 | 40 | 3 | CID000189134 | |
| Drug | AC1LAMW2 | 2.01e-08 | 4 | 40 | 3 | CID000491364 | |
| Drug | FdUrd-C8 | 2.01e-08 | 4 | 40 | 3 | CID000094262 | |
| Drug | Mem-CC | 2.01e-08 | 4 | 40 | 3 | CID003081269 | |
| Drug | 5-deoxyribose-1-phosphate | 2.01e-08 | 4 | 40 | 3 | CID000135786 | |
| Drug | ingliforib | 2.01e-08 | 4 | 40 | 3 | CID006451325 | |
| Drug | uric acid riboside | 2.01e-08 | 4 | 40 | 3 | CID000164933 | |
| Drug | pseudo-dl-glucose | 2.01e-08 | 4 | 40 | 3 | CID000125259 | |
| Drug | BCIp4A | 2.01e-08 | 4 | 40 | 3 | CID000192417 | |
| Drug | pyridoxal diphosphate | 2.01e-08 | 4 | 40 | 3 | CID000125696 | |
| Drug | 3'-chloromethotrexate | 2.01e-08 | 4 | 40 | 3 | CID000097703 | |
| Drug | Pyridoxal Phosphate | 3.48e-08 | 53 | 40 | 5 | DB00114 | |
| Drug | heptulose-2-P | 5.01e-08 | 5 | 40 | 3 | CID000124823 | |
| Drug | m-anisidine | 5.01e-08 | 5 | 40 | 3 | CID000010824 | |
| Drug | 6-FPLP | 5.01e-08 | 5 | 40 | 3 | CID000146246 | |
| Drug | gluconohydroximo-1,5-lactone | 5.01e-08 | 5 | 40 | 3 | CID009576855 | |
| Drug | 2-hydroxypropylphosphonate | 5.01e-08 | 5 | 40 | 3 | CID000441028 | |
| Drug | DHPBU | 5.01e-08 | 5 | 40 | 3 | CID000125914 | |
| Drug | 6-FDPL | 5.01e-08 | 5 | 40 | 3 | CID000129578 | |
| Drug | 5'-isobutylthioinosine | 5.01e-08 | 5 | 40 | 3 | CID003080910 | |
| Drug | 3'-O-methylpyridoxal 5'-phosphate | 5.01e-08 | 5 | 40 | 3 | CID003082179 | |
| Drug | GlcMan | 5.01e-08 | 5 | 40 | 3 | CID000152120 | |
| Drug | U66985 | 5.01e-08 | 5 | 40 | 3 | CID000127224 | |
| Drug | indirubin-5-sulphonate | 5.01e-08 | 5 | 40 | 3 | CID005288641 | |
| Drug | AC1O3M08 | 5.01e-08 | 5 | 40 | 3 | CID006331955 | |
| Drug | AC1LCUXJ | 5.01e-08 | 5 | 40 | 3 | CID000656425 | |
| Drug | 6-amino-5-bromouracil | 5.01e-08 | 5 | 40 | 3 | CID000080578 | |
| Drug | etafenone | 5.01e-08 | 5 | 40 | 3 | CID000003275 | |
| Drug | ddEtUrd | 5.01e-08 | 5 | 40 | 3 | CID000451452 | |
| Drug | 5-trifluoromethyl-2'-deoxycytidine | 5.01e-08 | 5 | 40 | 3 | CID000125618 | |
| Drug | pSer | 8.38e-08 | 126 | 40 | 6 | CID000000106 | |
| Drug | CV-araU | 1.00e-07 | 6 | 40 | 3 | CID006441877 | |
| Drug | 2-thiothymidine | 1.00e-07 | 6 | 40 | 3 | CID003005944 | |
| Drug | Carbocyclic Bvdc | 1.00e-07 | 6 | 40 | 3 | CID006438602 | |
| Drug | DNPP | 1.00e-07 | 6 | 40 | 3 | CID000067056 | |
| Drug | 5-chloro-indole-2-carboxylic acid | 1.00e-07 | 6 | 40 | 3 | CID000082693 | |
| Drug | 2,2-dimethyl-3-hydroxybutyric acid | 1.00e-07 | 6 | 40 | 3 | CID000152984 | |
| Drug | EdUMP | 1.00e-07 | 6 | 40 | 3 | CID003085112 | |
| Drug | 5'-deoxy-5'-chloroformycin | 1.00e-07 | 6 | 40 | 3 | CID000126430 | |
| Drug | NSC-97433 | 1.00e-07 | 6 | 40 | 3 | CID000001803 | |
| Drug | 5-n-propylthioadenosine | 1.00e-07 | 6 | 40 | 3 | CID000656428 | |
| Drug | AzddCyd | 1.00e-07 | 6 | 40 | 3 | CID000451374 | |
| Drug | 5-Ffdru | 1.00e-07 | 6 | 40 | 3 | CID000065561 | |
| Drug | AR-L57 | 1.00e-07 | 6 | 40 | 3 | CID000156890 | |
| Drug | Carbocyclic Ivdu | 1.00e-07 | 6 | 40 | 3 | CID006439191 | |
| Drug | alpha-(fluoromethyl)dehydroornithine | 1.75e-07 | 7 | 40 | 3 | CID006439607 | |
| Drug | 6-fluoropyridoxal | 1.75e-07 | 7 | 40 | 3 | CID003080803 | |
| Drug | 2',3'-dideoxy-3'-fluorocytidine | 1.75e-07 | 7 | 40 | 3 | CID000356019 | |
| Drug | heptenitol | 1.75e-07 | 7 | 40 | 3 | CID000188267 | |
| Drug | AC1L3372 | 1.75e-07 | 7 | 40 | 3 | CID000108025 | |
| Drug | 1 Gpt | 1.75e-07 | 7 | 40 | 3 | CID000101247 | |
| Drug | formycins | 1.75e-07 | 7 | 40 | 3 | CID000512867 | |
| Drug | Promonta | 1.75e-07 | 7 | 40 | 3 | CID000108494 | |
| Drug | 5'-methylthioinosine | 1.75e-07 | 7 | 40 | 3 | CID000161214 | |
| Drug | hydantocidin | 1.75e-07 | 7 | 40 | 3 | CID000125429 | |
| Drug | AC1NUVX5 | 2.80e-07 | 8 | 40 | 3 | CID005461894 | |
| Drug | 6-methylpurine | 2.80e-07 | 8 | 40 | 3 | CID005287547 | |
| Drug | amorphin | 2.80e-07 | 8 | 40 | 3 | CID000122792 | |
| Drug | Etafenone [inn] | 2.80e-07 | 8 | 40 | 3 | CID000066659 | |
| Drug | 6-benzyl-2-thiouracil | 4.19e-07 | 9 | 40 | 3 | CID000685814 | |
| Drug | 5'-methylthiotubercidin | 4.19e-07 | 9 | 40 | 3 | CID000188350 | |
| Drug | alpha-maltosyl fluoride | 4.19e-07 | 9 | 40 | 3 | CID000194237 | |
| Drug | 5-Iodoribose 1-phosphate | 4.19e-07 | 9 | 40 | 3 | CID003035973 | |
| Drug | 5'-iodo-5'-deoxyadenosine | 4.19e-07 | 9 | 40 | 3 | CID000107502 | |
| Drug | 8-azidoadenosine 5'-monophosphate | 5.98e-07 | 10 | 40 | 3 | CID000124726 | |
| Drug | 2,6-dihydroxypyridine | 5.98e-07 | 10 | 40 | 3 | CID000069371 | |
| Drug | 6-methyluridine | 5.98e-07 | 10 | 40 | 3 | CID000092887 | |
| Drug | UDP-pyridoxal | 5.98e-07 | 10 | 40 | 3 | CID000126789 | |
| Drug | maltohexaose | 6.42e-07 | 39 | 40 | 4 | CID000439606 | |
| Drug | glucosyl fluoride | 8.21e-07 | 11 | 40 | 3 | CID000150967 | |
| Drug | Cid 11299980 | 8.21e-07 | 11 | 40 | 3 | CID009856533 | |
| Drug | 9 Da | 8.21e-07 | 11 | 40 | 3 | CID005287565 | |
| Drug | BCX-34 | 1.09e-06 | 12 | 40 | 3 | CID000060817 | |
| Drug | Ap4U | 1.09e-06 | 12 | 40 | 3 | CID000165888 | |
| Drug | phenylurethane | 1.09e-06 | 12 | 40 | 3 | CID000007591 | |
| Drug | acyclothymidine | 1.09e-06 | 12 | 40 | 3 | CID000072358 | |
| Drug | 5'-deoxypyridoxal | 1.09e-06 | 12 | 40 | 3 | CID000164889 | |
| Disease | apolipoprotein B measurement | 1.62e-04 | 663 | 37 | 6 | EFO_0004615 | |
| Disease | systemic mastocytosis | 4.51e-04 | 25 | 37 | 2 | MONDO_0016586 | |
| Disease | Glycogen Storage Disease | 5.26e-04 | 27 | 37 | 2 | C0017919 | |
| Disease | non-high density lipoprotein cholesterol measurement | 1.87e-03 | 713 | 37 | 5 | EFO_0005689 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 2.64e-03 | 220 | 37 | 3 | EFO_0004529, EFO_0008317 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 2.77e-03 | 224 | 37 | 3 | EFO_0004530, EFO_0008317 | |
| Disease | schizophrenia (implicated_via_orthology) | 3.31e-03 | 68 | 37 | 2 | DOID:5419 (implicated_via_orthology) | |
| Disease | Drugs used in diabetes use measurement | 3.99e-03 | 255 | 37 | 3 | EFO_0009924 | |
| Disease | Esophageal Neoplasms | 4.33e-03 | 78 | 37 | 2 | C0014859 | |
| Disease | Malignant neoplasm of esophagus | 4.33e-03 | 78 | 37 | 2 | C0546837 | |
| Disease | urate measurement | 4.95e-03 | 895 | 37 | 5 | EFO_0004531 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YSGYYLLGQGRRGHR | 226 | P0C7U0 | |
| ERYGYGLGTGGYSYI | 376 | Q6Y288 | |
| YLAYTGLGRGYQVKG | 401 | Q9NQ94 | |
| FGEGYSGLEYDYRGL | 506 | Q92624 | |
| YSEGYPGKRYYGGAE | 96 | P34897 | |
| GYRHGRGKFYYASGA | 291 | P0C881 | |
| GYRHGRGKFYYASGA | 291 | B2RC85 | |
| RGYIIGYGVGSPYAE | 756 | P43146 | |
| LGGKYYFRGDLGGYN | 111 | P20916 | |
| NYDGICYLGGFEYGR | 3101 | Q5T1H1 | |
| AGVILGGAYLYKYFA | 66 | Q9Y287 | |
| QASRYLLYYYGGGGA | 96 | P0DKB6 | |
| LLYYYGGGGAEAKAR | 101 | P0DKB6 | |
| GGGGKRYRAVYDYSA | 201 | Q14847 | |
| EGYLAYYLQGGFSRF | 116 | Q99956 | |
| YDYYGGEVGEGRIFA | 356 | Q6PEW0 | |
| HGQYYDLLRLFEYGG | 66 | P62136 | |
| FIYGYEYLGNSGRLV | 1541 | Q9P2D7 | |
| AGLRYGYEYLGNSPR | 1286 | Q8WXX0 | |
| GAGYTDVYGDYRPLF | 1386 | Q9BZC7 | |
| YRSPGGYKGFDTYRG | 876 | Q6IMN6 | |
| GYNGELYIFGGYNAR | 246 | Q9BQ90 | |
| NYYGGLRYGYGVLGG | 6 | Q3LI61 | |
| YPAYASGGGYVIAGR | 301 | Q7Z7M8 | |
| TFGYGYEYMGLNGRL | 1791 | Q8IVF4 | |
| YEFYKLYLVGGAQGR | 76 | Q15768 | |
| YLGGEAYWAGGLHLY | 361 | Q9Y512 | |
| YVGYLVDAEGGDIYG | 4181 | Q9NZJ4 | |
| GYPGQRYYGGTEFID | 76 | P34896 | |
| SVLFYGYYGRERKIG | 206 | Q7Z5M5 | |
| YRIHAGDVYLYGGRG | 126 | A6NIE9 | |
| GAFLGAGIVFGLYYD | 111 | Q92482 | |
| NCYGGGGRYEEYRGR | 661 | Q8N7X1 | |
| LGLAAYGYGIRYEFG | 151 | P11217 | |
| LVTGGGYAGYRQYEK | 71 | Q9UG56 | |
| LGLAAYGYGIRYEFG | 151 | P11216 | |
| YGALYEGRNPGFYVE | 771 | P19174 | |
| HGQYYDLLRLFEYGG | 66 | P36873 | |
| YGLCGIHYIDAGYLG | 681 | Q8WUA4 | |
| RGYLYGGLEFGAECY | 166 | Q2TBF2 | |
| LGLAAYGYGIRYEYG | 151 | P06737 | |
| GLYYLYCLVGYRGRA | 131 | Q06643 |